Modification of immunosuppressive agents in a kidney transplant recipient with COVID-19 and acute kidney injury
Conclusions: In this case, successful modification of this immunosuppressive regimen was accomplished to reduce drug interaction complications, aiming to avoid calcineurin inhibitor nephrotoxicity while maintaining appropriate levels of immunosuppression to prevent organ rejection and to promote the patient ’s recovery from infection.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Source Type: research
More News: Coronavirus | COVID-19 | Epidemiology | Infectious Diseases | Kaletra | Kidney Transplant | Kidney Transplantation | Norvir | Outbreaks | Pneumonia | Prograf | Tacrolimus | Thailand Health | Transplant Surgery | Transplants | Urology & Nephrology